These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32770123)

  • 21. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].
    Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748
    [No Abstract]   [Full Text] [Related]  

  • 22. A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.
    Dashti NK; Dickson BC; Zhang L; Xie Z; Nielsen GP; Antonescu CR
    Genes Chromosomes Cancer; 2021 Nov; 60(11):762-771. PubMed ID: 34310785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
    Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
    Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
    Antonescu CR; Dal Cin P; Nafa K; Teot LA; Surti U; Fletcher CD; Ladanyi M
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1051-60. PubMed ID: 17724745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.
    Antonescu CR; Dickson BC; Zhang L; Sung YS; Fletcher CD
    Mod Pathol; 2021 Aug; 34(8):1541-1546. PubMed ID: 33859361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.
    Hiemenz MC; Kaur J; Kuang Z; Huang RSP; Harries L; Metzger D; Schiavone K; Millis SZ; Lin DI; Lechpammer M; Decker B; Mata DA; Reddy A; Parke M; Lee EY; Cui X; Iwenofu OH; Buehler D; Henderson L; Baldwin EM; Boikos SA; Ramkissoon SH; Smith SC
    Genes Chromosomes Cancer; 2023 Aug; 62(8):460-470. PubMed ID: 36862145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EWSR1::ATF1 fusions characterize a group of extra-abdominal epithelioid and round cell mesenchymal neoplasms, phenotypically overlapping with sclerosing epithelioid fibrosarcomas, and intra-abdominal FET::CREB fusion neoplasms.
    Rekhi B; Dermawan JK; Fritchie KJ; Zimpfer A; Mohammad TM; Ali FS; Nandy K; Zou Y; Stoehr R; Agaimy A
    Virchows Arch; 2024 Jul; ():. PubMed ID: 39031200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EWSR1-CREM fusion in pulmonary mesenchymal neoplasm showing distinctive clear cell morphology.
    Komatsu M; Sakai Y; Nishikubo M; Tane S; Nishio W; Kajimoto K; Hirose T
    Pathol Int; 2020 Dec; 70(12):1020-1026. PubMed ID: 33002291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial myxoid angiomatoid fibrous histiocytoma with "classic" histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors.
    Tan NJH; Pratiseyo PD; Wahjoepramono EJ; Kuick CH; Goh JY; Chang KTE; Tan CL
    Neuropathology; 2021 Aug; 41(4):306-314. PubMed ID: 34254369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates.
    Dermawan JK; Vanoli F; Herviou L; Sung YS; Zhang L; Singer S; Tap WD; Benayed R; Bale TA; Benhamida JK; Dickson BC; Antonescu CR
    Mod Pathol; 2022 Aug; 35(8):1055-1065. PubMed ID: 35347249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions.
    Lee PH; Kao YC; Hsieh TH; Liao JB; Li CF; Lee JC; Chang YM; Chang CD; Huang SC; Chen TJ; Liu TT; Yu SC; Huang HY
    Pathol Res Pract; 2022 Jan; 229():153700. PubMed ID: 34929603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of intracranial myxoid mesenchymal tumor with EWSR1:CREM fusion in an adult female: Extensive immunohistochemical evaluation.
    Kambe A; Kuwamoto S; Shimizu T; Amisaki H; Sakamoto M; Inagaki H; Kurosaki M
    Neuropathology; 2021 Aug; 41(4):315-323. PubMed ID: 34258808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions.
    Antonescu CR; Rosenberg AE; Xie Z; Zhang L; Perell KA; Loya AC
    Genes Chromosomes Cancer; 2021 Sep; 60(9):616-622. PubMed ID: 33987888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.
    Mezzacappa FM; Smith FK; Zhang W; Gard A; Cabuk FK; Gonzalez-Gomez I; Monforte HL; Liang J; Singh O; Quezado MM; Aldape KD; Gokden M; Bridge JA; Chen J
    Acta Neuropathol Commun; 2024 Jan; 12(1):17. PubMed ID: 38291529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
    Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
    Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review.
    Gareton A; Pierron G; Mokhtari K; Tran S; Tauziède-Espariat A; Pallud J; Louvel G; Meary E; Capelle L; Chrétien F; Varlet P
    J Neuropathol Exp Neurol; 2018 Jul; 77(7):537-541. PubMed ID: 29788195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
    Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR
    Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.